Cargando…
Sensitive Biomarker Analysis of Xue-Fu-Zhu-Yu Capsule for Patients with Qi Stagnation and Blood Stasis Pattern: A Nested Case-Control Study
OBJECTIVES: To identify the sensitive biomarker to predict the effectiveness of Xue-Fu-Zhu-Yu capsules (XFZYC). METHODS: This nested case-control study included 5 patients with response to XFZYC in the treatment group, 5 patients with no response to XFZYC also in the treatment group, and 5 patients...
Autores principales: | Chen, Guang, He, Haoqiang, Hu, Kun, Gao, Jialiang, Li, Jun, Han, Mei, Wang, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885824/ https://www.ncbi.nlm.nih.gov/pubmed/31827557 http://dx.doi.org/10.1155/2019/7182865 |
Ejemplares similares
-
Xue-Fu-Zhu-Yu capsule in the treatment of qi stagnation and blood stasis syndrome: a study protocol for a randomised controlled pilot and feasibility trial
por: He, Haoqiang, et al.
Publicado: (2018) -
Uncovering the potential mechanism of Xue Fu Zhu Yu Decoction in the treatment of intracerebral hemorrhage
por: Xue, Dao-jin, et al.
Publicado: (2022) -
Identification of differentially expressed non-coding RNAs and mRNAs involved in Qi stagnation and blood stasis syndrome
por: Chen, Guang, et al.
Publicado: (2019) -
Efficacy and Safety of Xue-Fu-Zhu-Yu Decoction for Patients with Coronary Heart Disease: A Systematic Review and Meta-Analysis
por: Zhang, Shuo, et al.
Publicado: (2021) -
The Improvement of Cardiac and Endothelial Functions of Xue-Fu-Zhu-Yu Decoction for Patients with Acute Coronary Syndrome: A Meta-Analysis of Randomized Controlled Trials
por: Chen, Shiqi, et al.
Publicado: (2022)